VASA Project Data (to be available)
I. Phase Ia US trial
II. Phase Ib trial in Burkina Faso
III. Phase Ib trial in Madagascar
IV. Human Challenge Trial
V. Cost of Illness Study
VI. Cost Effectiveness Analysis
VII. Immune Signature Study
VIII. Correlate Efficacy Study
IX. Sero-epidemiology study in Burkina Faso
X. Sero-epidemiology study in Madagascar